Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04222907
Other study ID # 0008-17
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2015
Est. completion date September 20, 2019

Study information

Verified date April 2017
Source Assuta Hospital Systems
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.


Description:

There have been few studies in recent years, which has prompted us to undertake this study. Our aim was to examine the current colonization rates and attack rates in the Israeli population. Our secondary aim was to evaluate the need to readjust recommendations towards universal screening.


Recruitment information / eligibility

Status Completed
Enrollment 54759
Est. completion date September 20, 2019
Est. primary completion date September 20, 2016
Accepts healthy volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS)

Exclusion Criteria:

- repeat pregnancies occurring in the same woman during the time period

- multiple pregnancies

- gestational age greater than 42 weeks due to probability of data inaccuracy

- women with missing information

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assuta Hospital Systems

Outcome

Type Measure Description Time frame Safety issue
Primary Attack rate of early-onset GBS disease (EOGBSD) Attack rate of (EOGBSD) 2015-2016